Latest News

RetailMeNot, a Ziff Davis (NasdaqGS:ZD) company, has launched a Guaranteed Cash Back program that offers assured and stackable rewards for shoppers. Ziff Davis completed its exit from the Games Publishing business in Q4 2025, refocusing on its core operations. For you as an investor, these moves sit at the heart of what Ziff Davis does today: a mix of digital media, subscription based services, and advertising supported platforms. RetailMeNot’s Guaranteed Cash Back program reflects how...

CorMedix (NasdaqGM:CRMD) has agreed to acquire Melinta Therapeutics, adding seven approved therapies to its commercial portfolio. The transaction expands CorMedix's presence in hospital and acute care settings through a broader anti infective offering. The deal marks a shift from a single product focused model toward a multi asset commercial platform. For you as an investor, CorMedix has largely been known for its focus on infection prevention products in high risk settings. By bringing...

Krispy Kreme (DNUT) is back in the spotlight after expanding its collaboration with the Oreo brand, rolling out a limited time cookie themed doughnut collection that sits alongside its recent earnings release. See our latest analysis for Krispy Kreme. The Oreo collaboration and recent earnings update come after a sharp rebound in the short term, with a 7 day share price return of 23.76% and 30 day share price return of 18.67%. However, this sits against a 1 year total shareholder return...

Enovis (NYSE:ENOV) recorded a goodwill impairment charge of over $500 million in Q4 2025, tied to changes in its business mix and accounting assumptions. The company reported strong organic growth in key segments in the same period, supported by new product launches. Recently introduced products, including the Nebula Stem and OrthoDrive Impactor, are gaining traction, with Nebula competing directly against established peers. For investors tracking Enovis, the combination of a large goodwill...

In February 2026, Singapore Airlines reported that January group passenger capacity, traffic, and passengers carried all rose year on year, while passenger load factor eased slightly, and cargo operations saw marginally lower capacity but a higher cargo load factor with more cargo and mail carried. The airline’s operating update came alongside record quarterly revenue and a roughly 26% rise in operating profit, as passenger volumes in December surpassed pre-pandemic levels and the group...

Mobileye Global (NasdaqGS:MBLY) is adding Elektrobit’s Linux platform to its Mobileye Drive system to support Level 4 autonomous driving. The company recently secured a major U.S. OEM win for its advanced driver assistance systems, expanding its ADAS pipeline. Mobileye signed a SuperVision agreement with Mahindra & Mahindra, positioning itself as a Tier 1 supplier and opening new geographic markets. Mobileye Global, known for its driver assistance and autonomous driving technology, is...

If you are wondering whether Aveanna Healthcare Holdings is still attractively priced after its recent run, you are not alone. This article focuses on what the current share price could imply about value. The stock last closed at US$7.36, with returns of 0.3% over 7 days, a 10.8% decline over 30 days, an 8.9% decline year to date, and a 72.8% gain over the past year, as well as a very large 3 year return of around 4x. Recent coverage has centred on Aveanna's role in home and pediatric...

If you are wondering whether uniQure’s current share price reflects its true worth, this breakdown is designed to help you weigh what you are paying against what you are getting. The stock closed at US$15.63, with returns of a 33.3% decline over 7 days, a 32.1% decline over 30 days, a 33.2% decline year to date, but an 18.9% gain over the past year, which may catch the eye of investors thinking about both risk and recovery potential. Recent news around uniQure has focused on its position in...

LeMaitre Vascular (NasdaqGM:LMAT) reported robust Q4 2025 and full-year 2025 financial results. The company announced a new US$100 million share repurchase program. Management approved a 25% dividend increase for shareholders. LeMaitre Vascular focuses on medical devices for vascular surgeons, so its performance tends to track demand for procedures that treat peripheral vascular disease and related conditions. The combination of strong quarterly and full-year 2025 figures with higher...

Adyen has partnered with Medius to roll out a corporate card program with cashback rewards aimed at finance teams across Europe and the UK. The company has also teamed up with Mesh Payments to support local currency corporate cards and expense management for multinational clients. Together, these partnerships expand Adyen's presence in corporate payments and spend management solutions in Europe and the UK. Adyen (ENXTAM:ADYEN), currently trading at about €994.8 per share, is pushing further...

Metals X FY 2025: Earnings, Revenue and Margins Under the Microscope Metals X (ASX:MLX) has put fresh numbers on the table for FY 2025, with first half revenue of A$147.5 million and basic EPS of A$0.0583 setting the tone against a trailing twelve month picture that shows A$285.0 million of revenue and EPS of A$0.118. Over the last few reporting periods the company has seen revenue move from A$94.9 million and EPS of A$0.0164 in 1H FY 2024 to A$123.8 million and EPS of A$0.0973 in 2H FY 2024,...

CNMC Goldmine Holdings (Catalist:5TP) has opened FY 2025 with first half revenue of US$52.8 million, basic EPS of US$0.0389 and net income of US$15.8 million, against a backdrop of very large earnings growth over the past year and a trailing net margin of 32.7%. Over the last 12 months, the company has seen revenue move from US$65.2 million with EPS of US$0.0243 to trailing revenue of US$128.6 million and EPS of US$0.1036, while half year revenue stepped from US$29.7 million and US$35.5...

Neuren Pharmaceuticals (ASX:NEU) has opened FY 2025 with first half revenue of A$28.3 million and basic EPS of A$0.12, setting a different tone from the prior half, when the company recorded A$192.5 million of revenue and basic EPS of A$1.05. The company has seen revenue move from A$26.2 million and basic EPS of A$0.06 in the first half of FY 2024 to A$28.3 million and A$0.12 in the latest period. Trailing twelve month EPS sits at A$1.17 on revenue of A$218.9 million, giving investors a clear...

Virgin Australia Holdings (ASX:VGN) kicked off H1 2026 results season with trailing twelve month revenue of about A$6.1b and net income of A$346.5m, framing the latest half year print of A$2.7b in revenue and A$5.5m in net income against a period where profitability has already compressed from earlier highs. The company has seen revenue move from A$2.6b in H2 2024 to A$3.0b in H1 2025 and A$2.7b in H2 2025, while net income shifted from A$44.4m to A$473m and then A$5.5m. This leaves investors...

Clarity Pharmaceuticals (ASX:CU6) has posted its H1 2026 scorecard, with investors watching how its revenue base and per share losses are tracking against ambitious growth expectations. The company has seen half year revenue move from A$6.1 million in H2 2024 to A$4.7 million in H1 2025 and A$4.8 million in H2 2025. Over the same periods, basic EPS moved from a loss of A$0.09 per share in H2 2024 to losses of A$0.07 in H1 2025 and A$0.13 in H2 2025. This sets the scene for a results season...

Earlier this week, OLAPLEX Holdings, Inc. launched No.3PLUS Complete Repair Treatment, a three-minute pre-shampoo product using its patented Bond Building Technology™ and new Damage Defense Cationic Complex, supported by a “Science Never Looked So Good” campaign featuring Chloe Fineman and broad distribution across major retail and online channels. This new treatment extends OLAPLEX’s core bond-repair franchise into a faster, more convenient format, aiming to reinforce its science-led brand...

Singapore Technologies Engineering (SGX:S63) has kicked off FY 2025 with first half revenue of S$5.9b and basic EPS of S$0.13, setting the tone for how the rest of the year might look after its latest earnings release. The company has seen revenue move from S$5.5b and EPS of S$0.11 in 1H 2024 to S$5.8b and EPS of S$0.12 in 2H 2024, before landing at S$5.9b and EPS of S$0.13 in 1H 2025. This progression gives investors a clearer view of how the top and bottom line have been tracking into the...

Xinyi Glass Holdings (SEHK:868) has put fresh numbers on the table for FY 2025, with first half revenue of C¥9.8b and basic EPS of C¥0.23, setting the tone for how the rest of the year might shape up. The company has seen revenue move from C¥10.9b in the first half of 2024 to C¥9.8b in the latest half, while EPS has shifted from C¥0.59 to C¥0.23. These shifts sit against trailing twelve month EPS of C¥0.62 on revenue of C¥20.8b. With trailing net margin at 13.1% versus 15.1% a year earlier,...

If you are wondering whether Lasertec is still reasonably priced after its strong run, this article explains how the current share price compares with several valuation yardsticks. With the stock at ¥33,660 and returns of 9.9% over 7 days, a 14.2% decline over 30 days, 6.1% year to date, 155.7% over 1 year, 58.0% over 3 years and 178.1% over 5 years, many investors are asking what is already priced in and how much risk they are taking on at these levels. Recent coverage of Lasertec has...

SPS Commerce (NasdaqGS:SPSC) reported earnings per share that were ahead of expectations, highlighting resilient profitability. Shortly after the results, the CEO sold company shares, drawing attention to insider activity. Craig Hallum downgraded the stock, citing a revenue miss and a softer outlook for 2026. SPS Commerce focuses on cloud based supply chain and retail data services, giving retailers and suppliers tools to manage orders and product information. That positions the company in...

If you are wondering whether Técnicas Reunidas is still attractively priced after its recent run, you are not alone. This article is aimed squarely at that question. The stock most recently closed at €36.96, with returns of 5.0% over 7 days, 19.2% over 30 days, 30.8% year to date, 139.7% over 1 year and 253.5% over 3 years, which may affect how you think about its current risk and reward balance. Alongside these moves, investors have been reacting to ongoing project activity and contract...

Applied Optoelectronics (AAOI) closed out FY 2025 with fourth quarter revenue of US$134.3 million and a basic EPS loss of US$0.03, alongside net income excluding extra items of a US$2.0 million loss. This puts the focus squarely on how efficiently that top line is being converted into earnings. The company has seen quarterly revenue move from US$65.2 million in Q3 2024 to US$100.3 million in Q4 2024, then to US$99.9 million in Q1 2025, US$103.0 million in Q2 2025, US$118.6 million in Q3 2025...

Aichi Steel (TSE:5482) has put corporate governance in focus after its February 27 board meeting, where directors backed a shift to a company with an Audit and Supervisory Committee, pending shareholder approval in June. See our latest analysis for Aichi Steel. The governance shift comes as the stock has been on a strong run, with a 1 day share price return of 4.32% and a 30 day share price return of 11.62%. The 1 year total shareholder return is about double and the 3 year total shareholder...

Pinnacle West Capital (NYSE:PNW) entered a new $300 million revolving credit facility, replacing its prior arrangement. The facility extends through 2031 and is intended to support general corporate purposes and ongoing infrastructure investments. For investors watching NYSE:PNW, this fresh $300 million credit line arrives with the stock around $100.3 per share, alongside returns of 13.8% year to date and 63.9% over 5 years. These figures provide a snapshot of how the market has valued the...